Loading
HKSEHealthcareMedical - Devices
Latest quote
HK$1.35
−HK$0.04 · -2.88%
Suzhou Basecare Medical Corporation Limited, an investment holding company established in Suzhou, China, in 2010, focuses its business activities within the People's Republic of China. The company primarily engages in the research, development, and manufacturing of genetic testing solutions specifically for assisted reproduction, alongside the distribution of related medical devices and instruments. Its extensive product line includes a range of genetic test kits for reproductive health. These comprise pre-implantation genetic tests such as PGT-A, designed to screen for chromosomal aneuploidies; PGT-M, which identifies single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits, used to detect chromosomal structural rearrangements often linked to recurrent miscarriages. Additionally, Basecare offers prenatal test kits (CNV kits) and postnatal test kits (WES kits). Complementing its genetic testing offerings, the company supplies various specialized medical equipment, including liquid nitrogen storage dewars, cryostorage systems, automated workstations, sperm quality analyzers, and next-generation sequencing (NGS) sequencers. Beyond manufacturing and sales, Basecare also provides marketing services and develops software for its medical devices and instruments. Its primary clientele consists of hospitals and reproductive clinics.
Latest quote
HK$1.35
−HK$0.04 · -2.88%
Regular session · HKT · Market data may be delayed.
Suzhou Basecare Medical Corporation Limited, an investment holding company established in Suzhou, China, in 2010, focuses its business activities within the People's Republic of China. The company primarily engages in the research, development, and manufacturing of genetic testing solutions specifically for assisted reproduction, alongside the distribution of related medical devices and instruments. Its extensive product line includes a range of genetic test kits for reproductive health. These comprise pre-implantation genetic tests such as PGT-A, designed to screen for chromosomal aneuploidies; PGT-M, which identifies single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits, used to detect chromosomal structural rearrangements often linked to recurrent miscarriages. Additionally, Basecare offers prenatal test kits (CNV kits) and postnatal test kits (WES kits). Complementing its genetic testing offerings, the company supplies various specialized medical equipment, including liquid nitrogen storage dewars, cryostorage systems, automated workstations, sperm quality analyzers, and next-generation sequencing (NGS) sequencers. Beyond manufacturing and sales, Basecare also provides marketing services and develops software for its medical devices and instruments. Its primary clientele consists of hospitals and reproductive clinics.
Day range
Current HK$1.35
52-week range
Current HK$1.35
Regular session · HKT · Market data may be delayed.
Suzhou Basecare Medical Corporation Limited, an investment holding company established in Suzhou, China, in 2010, focuses its business activities within the People's Republic of China. The company primarily engages in the research, development, and manufacturing of genetic testing solutions specifically for assisted reproduction, alongside the distribution of related medical devices and instruments. Its extensive product line includes a range of genetic test kits for reproductive health. These comprise pre-implantation genetic tests such as PGT-A, designed to screen for chromosomal aneuploidies; PGT-M, which identifies single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits, used to detect chromosomal structural rearrangements often linked to recurrent miscarriages. Additionally, Basecare offers prenatal test kits (CNV kits) and postnatal test kits (WES kits). Complementing its genetic testing offerings, the company supplies various specialized medical equipment, including liquid nitrogen storage dewars, cryostorage systems, automated workstations, sperm quality analyzers, and next-generation sequencing (NGS) sequencers. Beyond manufacturing and sales, Basecare also provides marketing services and develops software for its medical devices and instruments. Its primary clientele consists of hospitals and reproductive clinics.
Day range
Current HK$1.35
52-week range
Current HK$1.35
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 233.27M CNY | 299.11M CNY | 207.98M CNY | 140.9M CNY | 107.3M CNY |
| Cost of goods sold | 109.66M CNY | 162.89M CNY | 116.63M CNY | 81.37M CNY | 56.15M CNY |
| Gross profit | 123.61M CNY | 136.22M CNY | 91.35M CNY | 59.53M CNY | 51.15M CNY |
| Research and development | 106.42M CNY | 135.26M CNY | 129.57M CNY | 119.77M CNY | 73.71M CNY |
| Selling, general, and administrative | 231.97M CNY | 276.39M CNY | 209.3M CNY | 161.5M CNY | 114.64M CNY |
| Operating expenses | 337.69M CNY | 367.19M CNY | 285.06M CNY | 185.65M CNY | 175.63M CNY |
| Interest income | 11.8M CNY | 25.27M CNY | 38.51M CNY | 23.62M CNY | 18.2M CNY |
| Interest expense | 13.12M CNY | 9.37M CNY | 2.61M CNY | 496K CNY | 1.26M CNY |
| Depreciation and amortization | 43.79M CNY | 14.49M CNY | 19.57M CNY | 8.39M CNY | 5.59M CNY |
| Operating income | −214.08M CNY | −230.97M CNY | −193.71M CNY | −126.12M CNY | −124.49M CNY |
| Net income | −223.46M CNY | −237.03M CNY | −191.69M CNY | −123.16M CNY | −143.65M CNY |
Company facts updated Sep 10, 2026.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
